Co-diagnostics, inc. reports first quarter 2025 financial results

Salt lake city, may 08, 2025 (globe newswire) -- co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended march 31, 2025.
CODX Ratings Summary
CODX Quant Ranking